Skip to content
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Radiology

When Is Breast MRI Recommended for Breast Fibrosis?

At a Glance

Breast MRI is not automatically recommended when mammography or ultrasound suggests fibrosis. It may help clarify selected non-calcified or post-treatment findings and is used for high-risk screening, but a suspicious BI-RADS result generally requires an image-guided biopsy.

If a mammogram or ultrasound reveals a finding that might be breast fibrosis, a magnetic resonance imaging (MRI) scan is not automatically the next step. While imaging can suggest the presence of fibrous tissue, it cannot prove it without a tissue sample [1]. If a finding is highly suspicious, an image-guided biopsy is usually required, because an MRI cannot replace a biopsy [2]. However, an MRI is sometimes used as a selective problem-solving tool for confusing findings, or as a supplemental screening test for patients with a high risk of breast cancer [3] [4].

Why an MRI Cannot Always Replace a Biopsy

When imaging shows an area that could be fibrosis (benign, fibrous breast tissue) or something more concerning, it is natural to hope for a non-invasive scan rather than a needle biopsy. However, an MRI has limitations that prevent it from being a universal substitute for a biopsy.

  • Fibrosis can mimic cancer on an MRI: Contrast-enhanced breast MRI uses an intravenous contrast agent to highlight abnormal blood flow. Unfortunately, fibrocystic changes and stromal fibrosis can also absorb this contrast—a process known as enhancement [5] [6]. Radiologists evaluate the pattern and shape of the enhancement, but enhancement alone does not prove or rule out cancer [7].
  • MRI does not clearly show all microcalcifications: Breast MRI is highly sensitive, but it is less sensitive than mammography for detecting certain types of microcalcifications (tiny calcium deposits in the breast) [8]. If a mammogram shows highly suspicious calcifications, a stereotactic or tomosynthesis-guided biopsy is necessary regardless of what an MRI might show [9].
  • The risk of false positives: MRI scans are incredibly detailed and often detect harmless abnormalities. These false-positive results can lead to unnecessary anxiety, extra follow-up scans, and additional biopsies to investigate findings that turn out to be benign [10] [11].
  • Matching imaging with pathology: If you do have a biopsy, the resulting tissue diagnosis must make sense with the original imaging—a concept called radiologic-pathologic concordance. If a biopsy diagnoses benign stromal fibrosis, but the imaging looked highly suspicious, your doctor may still recommend repeating the biopsy or surgically removing the area [12].

When is a Breast MRI Useful?

While not every indeterminate finding needs an MRI, doctors selectively use the test when its high sensitivity can provide crucial information.

1. As a Selective Problem-Solving Tool

If a mammogram or ultrasound shows a confusing, non-calcified area (or an architectural distortion—tissue that looks pulled or distorted without a clear lump), an MRI can sometimes serve as a problem-solving test [3]. In carefully selected cases after standard diagnostic imaging is complete, an MRI may help distinguish normal tissue from an area requiring biopsy [13]. However, MRI is not used to delay a biopsy if one is already indicated.

2. Evaluating Previously Treated Breasts

If you have had breast surgery or radiation, it can be very difficult for standard mammograms or ultrasounds to tell the difference between benign surgical scar tissue and a recurrence of cancer [14]. An MRI may help distinguish between the two, though it is not perfect, as scar tissue can sometimes enhance as well [15].

3. High Inherited Risk

Sometimes, an MRI is recommended not to evaluate a specific suspected area of fibrosis, but as a separate, supplemental screening strategy alongside annual mammograms. Annual screening MRIs are recommended for individuals with a calculated lifetime breast cancer risk of 20% or higher (calculated by a genetics clinic using specific risk models), a known genetic mutation (such as BRCA1 or BRCA2), or a history of chest radiation between ages 10 and 30 [4].

Standard Management: Understanding Your BI-RADS Category

Radiologists use a standardized system called BI-RADS (Breast Imaging Reporting and Data System) to communicate how suspicious a finding is. Your BI-RADS category dictates the next step, which is rarely an immediate MRI:

BI-RADS Category What It Means Typical Next Step
0: Incomplete More information is needed. Additional diagnostic mammography or targeted ultrasound.
1: Negative No significant findings. Return to routine annual screening.
2: Benign A non-cancerous finding (like a simple cyst or stable fibroadenoma). Return to routine annual screening.
3: Probably Benign Very high likelihood of being benign (less than 2% risk of cancer). A follow-up mammogram or ultrasound in 6 months to monitor for changes [16] [17].
4: Suspicious Has features that could be cancer. Divided into 4A (low suspicion), 4B (moderate suspicion), and 4C (high suspicion). An image-guided biopsy (a needle sample taken while mammography or ultrasound guides its position) [2]. Note: A recommendation for biopsy does not mean you have cancer.
5: Highly Suggestive Almost certainly malignant. Biopsy is required.
6: Known Biopsy-Proven Cancer has already been confirmed. Surgical or oncological treatment planning.

Practical and Safety Considerations for MRI

If your care team is considering an MRI, be aware of these practical requirements:

  • Contrast Agent and Kidneys: Breast MRIs use a gadolinium-based contrast agent. If you have severe renal impairment, your kidney function will be checked beforehand, though modern contrast agents are very safe for most people [11].
  • Pregnancy: Gadolinium contrast is generally avoided during pregnancy unless absolutely essential. Always tell your care team if you are or might be pregnant.
  • Implanted Devices: Many modern implanted devices (like pacemakers) are “MRI-conditional,” meaning you can safely be scanned under specific conditions. You will need to provide the exact make and model of any implants to the imaging center.
  • Physical Constraints: MRI does not use ionizing radiation, but it requires lying face-down in an enclosed tube for 30 to 45 minutes, which can be challenging if you experience claustrophobia [11].
  • Cost and Accessibility: Breast MRI is expensive, often requires insurance pre-authorization, and is not available at all imaging facilities [18] [19].

Common questions in this guide

Does suspected breast fibrosis automatically mean I need a breast MRI?
No. MRI is usually considered selectively when mammography or ultrasound leaves a confusing, non-calcified finding, or when prior surgery or radiation makes scar tissue difficult to distinguish from cancer. If the imaging is suspicious enough to require a biopsy, MRI should not delay that biopsy.
Can a breast MRI confirm that a finding is fibrosis?
No. Fibrosis can take up contrast on MRI and look similar to cancer, so the MRI appearance alone cannot prove the diagnosis. A suspicious finding may still need an image-guided biopsy, and the biopsy result should match the imaging.
What does a BI-RADS 4 or 5 result mean for my next step?
BI-RADS is a standardized score used to describe how suspicious a breast imaging finding looks. A BI-RADS 4 result usually calls for an image-guided biopsy, while BI-RADS 5 requires biopsy; neither score alone confirms cancer because tissue examination establishes the diagnosis.
When is breast MRI used for high-risk breast cancer screening?
Annual supplemental breast MRI may be recommended alongside mammography for people whose calculated lifetime breast cancer risk is 20% or higher, those with BRCA1 or BRCA2 mutations, or those who had chest radiation between ages 10 and 30. The risk calculation is usually done with a standard risk calculator, often through a genetics or breast specialist.
What should I tell the imaging center before a contrast-enhanced breast MRI?
Tell the team if you are pregnant or might be pregnant, have severe kidney disease, or have an implanted device such as a pacemaker. Give them the exact make and model of any implant, and mention claustrophobia or other difficulty lying face-down for 30 to 45 minutes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What exact BI-RADS category was assigned to my mammogram or ultrasound, and what specific wording (like mass, calcifications, or architectural distortion) led to that category?
  2. 2.Are you recommending an MRI as a problem-solving tool, or should we be proceeding directly to an image-guided biopsy based on my BI-RADS score?
  3. 3.If I get an MRI and it shows something only visible on the MRI, what kind of biopsy or follow-up would be needed?
  4. 4.Can you compare this recent imaging finding with my prior mammograms or ultrasounds to see if it is new or changing?
  5. 5.Does my personal health history or family history give me a lifetime breast cancer risk of 20% or higher, qualifying me for annual supplemental screening MRIs?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (19)
  1. 1

    Fibrocystic Changes of the Breast: Radiologic-Pathologic Correlation of MRI.

    Choe AI, Kasales C, Mack J, et al.

    Journal of breast imaging 2022; (4(1)):48-55 doi:10.1093/jbi/wbab071.

    PMID: 38422411
  2. 2

    MRI in the Assessment of BI-RADS® 4 lesions.

    Leithner D, Wengert G, Helbich T, et al.

    Topics in magnetic resonance imaging : TMRI 2017; (26(5)):191-199 doi:10.1097/RMR.0000000000000138.

    PMID: 28961568
  3. 3

    Diagnostic Performance of Breast Magnetic Resonance Imaging in Non-Calcified Equivocal Breast Findings: Results from a Systematic Review and Meta-Analysis.

    Bennani-Baiti B, Bennani-Baiti N, Baltzer PA

    PloS one 2016; (11(8)):e0160346 doi:10.1371/journal.pone.0160346.

    PMID: 27482715
  4. 4

    Breast Cancer Screening for Women at Higher-Than-Average Risk: Updated Recommendations From the ACR.

    Monticciolo DL, Newell MS, Moy L, et al.

    Journal of the American College of Radiology : JACR 2023; (20(9)):902-914 doi:10.1016/j.jacr.2023.04.002.

    PMID: 37150275
  5. 5

    Breast Dynamic Contrast Enhanced MRI: Fibrocystic Changes Presenting as a Non-mass Enhancement Mimicking Malignancy.

    Milosevic ZC, Nadrljanski MM, Milovanovic ZM, et al.

    Radiology and oncology 2017; (51(2)):130-136 doi:10.1515/raon-2017-0016.

    PMID: 28740447
  6. 6

    Motion artifacts, lesion type, and parenchymal enhancement in breast MRI: what does really influence diagnostic accuracy?

    Clauser P, Dietzel M, Weber M, et al.

    Acta radiologica (Stockholm, Sweden : 1987) 2019; (60(1)):19-27 doi:10.1177/0284185118770918.

    PMID: 29667880
  7. 7

    Nonmass enhancement lesions of the breast on core needle biopsy: outcomes, frequency of malignancy, and pathologic findings.

    Bartels AK, Fadare O, Hasteh F, Zare SY

    Human pathology 2021; (111()):92-97 doi:10.1016/j.humpath.2021.03.003.

    PMID: 33722650
  8. 8

    Abbreviated Magnetic Resonance Imaging for Breast Cancer Screening: Concept, Early Results, and Considerations.

    Ko ES, Morris EA

    Korean journal of radiology 2019; (20(4)):533-541 doi:10.3348/kjr.2018.0722.

    PMID: 30887736
  9. 9

    MRI for the assessment of malignancy in BI-RADS 4 mammographic microcalcifications.

    Bennani-Baiti B, Dietzel M, Baltzer PA

    PloS one 2017; (12(11)):e0188679 doi:10.1371/journal.pone.0188679.

    PMID: 29190656
  10. 10

    Breast MRI as an adjunct to mammography for breast cancer screening in high-risk patients: retrospective review.

    Raikhlin A, Curpen B, Warner E, et al.

    AJR. American journal of roentgenology 2015; (204(4)):889-97 doi:10.2214/AJR.13.12264.

    PMID: 25794083
  11. 11

    Breast MRI: EUSOBI recommendations for women's information.

    Mann RM, Balleyguier C, Baltzer PA, et al.

    European radiology 2015; (25(12)):3669-78 doi:10.1007/s00330-015-3807-z.

    PMID: 26002130
  12. 12

    Breast Biopsies Under Magnetic Resonance Imaging Guidance: Challenges of an Essential but Imperfect Technique.

    Chevrier MC, David J, Khoury ME, et al.

    Current problems in diagnostic radiology 2016; (45(3)):193-204.

    PMID: 26272705
  13. 13

    Magnetic resonance imaging in diagnosis of indeterminate breast (BIRADS 3 & 4A) in a general population.

    Hernández L, Díaz GM, Posada C, Llano-Sierra A

    Insights into imaging 2021; (12(1)):149 doi:10.1186/s13244-021-01098-z.

    PMID: 34674056
  14. 14

    What's Hot in Breast MRI.

    Scaranelo AM

    Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes 2022; (73(1)):125-140 doi:10.1177/08465371211030944.

    PMID: 34384041
  15. 15

    Breast Cancer Screening With Mammography Plus Ultrasonography or Magnetic Resonance Imaging in Women 50 Years or Younger at Diagnosis and Treated With Breast Conservation Therapy.

    Cho N, Han W, Han BK, et al.

    JAMA oncology 2017; (3(11)):1495-1502 doi:10.1001/jamaoncol.2017.1256.

    PMID: 28655029
  16. 16

    BI-RADS 3: Current and Future Use of Probably Benign.

    Lee KA, Talati N, Oudsema R, et al.

    Current radiology reports 2018; (6(2)):5 doi:10.1007/s40134-018-0266-8.

    PMID: 29399419
  17. 17

    Image-guided Procedure Versus 2-year Follow-up for a BI-RADS 3 Probably Benign Lesion: A Cost Comparison Analysis.

    Ong A, Azizi A, Ambinder EB, et al.

    Journal of breast imaging 2021; (3(1)):57-63 doi:10.1093/jbi/wbaa087.

    PMID: 38424837
  18. 18

    Role of magnetic resonance imaging in breast cancer management.

    Radhakrishna S, Agarwal S, Parikh PM, et al.

    South Asian journal of cancer 2018; (7(2)):69-71 doi:10.4103/sajc.sajc_104_18.

    PMID: 29721466
  19. 19

    MRI breast screening revisited.

    Heller SL, Moy L

    Journal of magnetic resonance imaging : JMRI 2019; (49(5)):1212-1221 doi:10.1002/jmri.26547.

    PMID: 30693603

This page explains when breast MRI may be considered for suspected breast fibrosis for informational purposes only and does not constitute medical advice. Your radiologist or breast care team should interpret your imaging and recommend whether you need follow-up or biopsy.

Get notified when new evidence is published on breast fibrosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.